Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Patent
1996-03-05
1998-12-08
Cunningham, Thomas M.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
514 15, 530403, 530328, 4241851, 4241931, C12N 502, A61K 3900, C07K 706
Patent
active
058468269
ABSTRACT:
The invention involves cytolytic T cell lines which are specific for complexes of HLA-B44 molecules and nonamers which bind to these.
REFERENCES:
patent: 5342774 (1994-08-01), Boon et al.
patent: 5519117 (1996-05-01), Wolfel
Khanna et al 1992 J. Exp. Med. 176:169.
Van der Bruggen et al., "A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes On a Human Melanoma", Science 254: 1643-1647 (Dec. 1991).
Khanna et al., "Localization of Epstein-Barr Virus Cytotoxic T Cell Epitopes Using Recombinant Vaccinia: Implications for Vaccine Development", J. Exp. Med. 176: 169-176 (Jul. 1992).
Boon-Falleur Thierry
Coulie Pierre
Cunningham Thomas M.
Lubet Martha
Ludwig Institute for Cancer Research
LandOfFree
Isolated cytolytic T cell line specific to complexes of HLA-B44 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated cytolytic T cell line specific to complexes of HLA-B44 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated cytolytic T cell line specific to complexes of HLA-B44 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-176616